Indrayani Biotech Ltd

₹ 12.2 -0.33%

10 Sep - close price

About

Incorporated in 1992, Indrayani Biotech
Ltd is in the business of Foods & Hospitality, Engineering and Healthcare^[1]

Key Points

Business Overview:^[1]
IBL has multiple business units managed by an
independent team of field experts. It operates
in Food and Hospitality, Dairy, Healthcare & Pharma, Engineering, Biotech, Agriculture and Infrastructure

Website BSE

Market Cap ₹ 55.6 Cr.
Current Price ₹ 12.2
High / Low ₹ 49.0 / 10.2
Stock P/E
Book Value ₹ 15.9
Dividend Yield 0.00 %
ROCE -1.12 %
ROE -8.75 %
Face Value ₹ 10.0

Add ratio to table

Edit ratios

Pros

Stock is trading at 0.77 times its book value

Cons

Company has low interest coverage ratio.
Promoter holding is low: 33.3%
Company has a low return on equity of 5.79% over last 3 years.
Company might be capitalizing the interest cost
Earnings include an other income of Rs.4.14 Cr.
Company has high debtors of 164 days.
Promoter holding has decreased over last 3 years: -11.6%
Working capital days have increased from 114 days to 211 days

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Fast Moving Consumer Goods Fast Moving Consumer Goods Agricultural Food & other Products Other Agricultural Products

Edit Columns

Loading peers table ...

Detailed Comparison with:

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
	25.63	42.05	46.00	49.25	42.31	40.44	39.09	44.38	31.53	30.81	17.32	50.57	29.10
	22.60	36.85	40.67	46.07	39.77	33.15	35.64	34.21	25.55	25.70	14.40	53.45	25.62
Operating Profit	3.03	5.20	5.33	3.18	2.54	7.29	3.45	10.17	5.98	5.11	2.92	-2.88	3.48
OPM %	11.82%	12.37%	11.59%	6.46%	6.00%	18.03%	8.83%	22.92%	18.97%	16.59%	16.86%	-5.70%	11.96%
	0.39	1.96	0.08	2.05	0.01	0.09	0.08	1.03	0.04	0.30	0.00	2.78	1.06
Interest	0.97	1.15	1.21	2.23	2.03	0.93	1.41	5.51	0.83	1.42	1.03	-1.72	0.86
Depreciation	0.66	0.75	0.78	1.15	0.90	0.91	1.03	0.96	4.25	2.79	1.46	9.93	3.47
Profit before tax	1.79	5.26	3.42	1.85	-0.38	5.54	1.09	4.73	0.94	1.20	0.43	-8.31	0.21
Tax %	0.00%	0.00%	-0.88%	21.62%	15.79%	0.00%	0.00%	0.00%	9.57%	-1.67%	18.60%	2.53%	23.81%
	1.79	5.26	3.44	1.44	-0.45	5.54	1.08	4.73	0.85	1.21	0.35	-8.53	0.16
EPS in Rs	0.52	1.54	0.72	0.32	-0.13	1.62	0.22	0.85	0.19	0.13	0.05	-1.87	0.04
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

	Mar 2010	Mar 2011	Mar 2012	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	TTM
	0	39	58	50	21	61	163	165	130	128
	0	39	57	47	26	54	145	142	115	119
Operating Profit	-0	1	1	3	-5	7	17	24	15	9
OPM %	-105%	2%	1%	6%	-24%	11%	11%	14%	12%	7%
	0	0	0	0	-4	0	4	1	3	4
Interest	0	0	0	1	2	2	6	10	3	2
Depreciation	0	0	0	1	0	1	3	4	21	18
Profit before tax	-0	0	0	1	-11	4	12	11	-6	-6
Tax %	0%	150%	300%	0%	0%	0%	3%	5%	6%
	-0	-0	-0	1	-11	4	12	10	-6	-7
EPS in Rs		-0.14	-0.16	2.22	-3.28	1.30	2.55	1.40	-1.34	-1.65
Dividend Payout %	0%	0%	0%	0%	0%	0%	0%	0%	0%

Compounded Sales Growth
10 Years:	%
5 Years:	21%
3 Years:	29%
TTM:	-18%

Compounded Profit Growth
10 Years:	%
5 Years:	%
3 Years:	%
TTM:	-167%

Stock Price CAGR
10 Years:	%
5 Years:	8%
3 Years:	-49%
1 Year:	-75%

Return on Equity
10 Years:	%
5 Years:	3%
3 Years:	6%
Last Year:	-9%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

	Mar 2010	Mar 2011	Mar 2012	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Equity Capital	6	4	4	4	34	34	34	46	46
Reserves	-6	-0	-0	27	-15	-10	12	22	27
	0	0	0	14	16	19	79	113	137
	1	6	9	7	5	8	31	54	59
Total Liabilities	1	10	12	51	40	51	156	234	268
	1	6	6	17	15	17	57	62	58
CWIP	-0	0	0	14	14	13	14	20	26
Investments	0	0	0	0	0	0	0	0	0
	0	4	7	21	11	22	85	151	185
Total Assets	1	10	12	51	40	51	156	234	268

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

	Mar 2011	Mar 2012	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
	1	2	6	0	4	16	-30	-7
	-3	-0	-4	-1	-1	-47	-16	25
	2	-1	-1	-0	-3	33	44	-18
Net Cash Flow	0	1	1	-1	1	2	-2	-0

Ratios

Consolidated Figures in Rs. Crores / View Standalone

	Mar 2010	Mar 2011	Mar 2012	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Debtor Days	0	26	26	52	84	84	67	87	164
Inventory Days	365			57	25	14	44	159	146
Days Payable	365			70	77	52	81	141	83
Cash Conversion Cycle	0	26	26	38	32	46	30	106	227
Working Capital Days	-1,883	-22	-19	30	-59	-12	6	127	211
ROCE %		28%	12%		-13%	16%	23%	14%	-1%

Shareholding Pattern

Numbers in percentages

	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
	44.89%	44.89%	44.89%	44.89%	44.84%	33.63%	33.57%	33.48%	33.40%	33.28%	33.28%	33.28%
	19.17%	17.16%	17.02%	15.27%	13.11%	7.58%	6.75%	4.07%	5.59%	5.25%	3.66%	3.11%
	35.94%	37.96%	38.09%	39.84%	42.05%	58.78%	59.68%	62.46%	61.01%	61.49%	63.07%	63.62%
No. of Shareholders	22,049	22,112	21,919	22,435	22,590	23,034	23,958	24,132	24,419	25,254	25,126	25,704

	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Jun 2025
	59.39%	59.39%	72.22%	72.28%	50.39%	48.81%	44.89%	33.57%	33.28%	33.28%
	0.00%	0.00%	0.00%	0.00%	22.04%	22.04%	17.02%	6.75%	3.66%	3.11%
	40.61%	40.61%	27.78%	27.72%	27.57%	29.15%	38.09%	59.68%	63.07%	63.62%
No. of Shareholders	18,923	18,754	18,697	18,634	18,926	20,925	21,919	23,958	25,126	25,704

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

All

Indrayani Biotech Ltd

Indrayani Biotech Ltd

Peer comparison

Quarterly Results

Profit & Loss

Balance Sheet

Cash Flows

Ratios

Shareholding Pattern

Documents

Announcements

Annual reports